Clinical trial Recruiting at 2 sites Observational Ages 7 to 18

Intestinal microbiota in children and adolescents with eating disorders — a psychoneuroimmunology perspective

Official title: Getting Into the Guts of Eating Disorders in Children and Adolescents. A Perspective From Psychoneuroimmunology.

Run by Spanish National Research Council · NCT07066033 · Data updated 2026-11-12

This project will test whether the mix and activity of gut bacteria differ in children and adolescents with eating disorders and whether those differences relate to diet, symptoms, or one-year treatment outcomes.

More Eating Disorders trials

Quick facts

Study typeObservational
Ages7 Years to 18 Years
SexAll
Enrollment158 (estimated)
SponsorSpanish National Research Council
Government
Locations2 sites (Madrid, Madrid and 1 other locations)
StatusRecruiting
StartedAugust 29, 2024
Main results expectedDecember 2026
Study endsAugust 2027
Registry record updatedAugust 18, 2026
Trial IDNCT07066033 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children and adolescents aged 7.0–17.9 years with a DSM‑5 diagnosis of anorexia nervosa (restrictive or binge–purge), OSFED, or ARFID with first episode or symptom duration under one year and parental/adolescent consent.

Probably not a fit

Patients with long-standing or previously unsuccessfully treated eating disorders, current infections, certain endocrine or gastrointestinal diseases, severe neurodevelopmental disorders, or recent suicidal behavior are excluded and unlikely to benefit from the study results.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational cohort study enrolling patients aged 7 to 17.9 years with a recent-onset eating disorder to compare their intestinal microbiota composition and function with healthy peers. Researchers collect stool samples, dietary and lifestyle histories, and standardized measures of psychopathology and neuroendocrine markers at baseline, then follow clinical course to one year to see if baseline factors predict outcome. The study also compares microbiota signatures across eating disorder subtypes (AN restrictive, AN binge–purge, OSFED, ARFID). Laboratory work is done in collaboration with a national food science institute and a pediatric university hospital in Madrid.

Why it matters

Potential benefit: If successful, the study could identify gut microbiota patterns linked to symptoms or prognosis that help target future personalized interventions or guide diet-based support.

How similar studies have gone: Prior adult and some pediatric studies have reported microbiota differences in eating disorders but findings have been inconsistent and remain largely exploratory, so this approach is promising but not yet proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age: 7-17.9 years
* Diagnosis of Anorexia Nervosa, both restrictive (ANR) and binge-purging (ANBP) subtypes, Other Specified Feeding and Eating Disorders (OSFED), Avoidant/Restrictive Food Intake Disorder (ARFID) according to DSM-V (APA, 2013).
* Males and females
* First episode or less than 1 year evolution since initial symptoms
* Written informed consent by parent/tutor and also by the adolescent if age is more than 12 y.

Exclusion Criteria:

* Comorbidities: Current infectious disease at admission; Severe neurodevelopmental disorders with impaired language development; Moderate or severe intellectual disability; Endocrine disorders such as diabetes mellitus or thyroid disease; Celiac disease; Suicidal behaviors in the previous 3 months.
* Patients with previous unsuccessful treatments for more than one year.
* Use of the following medications before entering the study: laxatives, anabolic steroids, immunosuppressant drugs, Helicobacter pylori eradication treatment, thyroid hormones or antibiotic treatment in the previous two months
* Surgery in the previous month. Control group participants' exclusion criteria are the same plus the following: History with diagnosis of mental disease (including EDs). Current autoimmune or infectious disease.

Where it's running

  • Hospital Infantil Universitario Niño Jesús
    Madrid, Madrid, Spain
    Recruiting
  • Institute of Food Science and Technology and Nutrition (ICTAN, CSIC)
    Madrid, Madrid, Spain
    Recruiting

Study contacts

  • Principal investigator: Mar Faya, PhD, MD — Hospital Infantil Universitario Niño Jesús
  • Study coordinator: Esther Nova, PhD
  • Email: enova@ictan.csic.es
  • Phone: 34 5492300

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.